Biosimilars Workshop presented by ISOPP
Fee
- 49 GBP ISOPP 2019 Registrants
- 149 GBP Non ISOPP 2019 Registrants. Pre registration is required.
Note
The Workshop runs concurrently with the Introduction to Oncology Pharmacy Course. Participation is only possible in one or the other.
Workshop Description
This interactive Workshop will focus on the education needs of ISOPP / BOPA members, as identified in ISOPP’s recent needs assessment surveys around the use of Biosimilars, as well as the feedback collected regarding: the uptake of Biosimilars around the world, how the implementation has been managed, and what challenges are faced by pharmacists working on the implementation of Biosimilars.
Program at a Glance
13:00 Welcome and introduction
13:15 Session 1: Biosimilars – How are they developed and tested? (Sponsored by Accord)
14:00 Session 2: Case Studies - Comparing experiences of implementing Biosimilars around the world
14:45 Session 3: The challenges of bringing Biosimilars to market (Sponsored by Pfizer)
15:30 Afternoon tea
16:00 Session 4: Administration and patient safety
16:45 Session 5: Panel Discussion
17:30 End of workshop
Presenter Information
- Paresh Patel, Senior Biosimilar Business Development Manager, Accord, UK
- Simon Cheesman, Lead Haematology Pharmacist at UCLH, UK
- Jatinder Harchowal, Chief Pharmacist and Clinical Director, Royal Marsden Hospital, UK
- Glenn Myers, Clinical Pharmacist, The Moncton Hospital, Moncton, Canada
- Winnie Wanjiku Mwangi, Oncology and Clinical Pharmacist, Meru Teaching and Referral Hospital, Kenya
- Enrico Bovi, Pfizer, Tadworth, UK
- Geoff Saunders, Consultant Pharmacist, The Christie Hospital UK, UK